From laboratory models to small human trials, a new review explores whether popular metabolic drugs could help curb alcohol, nicotine, and drug use, while underscoring how much clinical testing still lies ahead
ImproBiome is a targeted prebiotic formula that nourishes the beneficial bacteria responsible for supporting your body's natural GLP-1 production while also helping to promote digestive comfort and regularity
and UK adopt GLP-1 treatments seasonally, and if, while on medication, their alcohol intake drops by around 40% (if the JAMA study is generalizable to a large scale) this could erase billions of pounds and dollars from industry revenues each year, only for much of that demand to rebound sharply when these drinkers cycle off
These drugs have become vital tools in addressing the root causes of chronic diseasesobesity, cardiovascular disorders, PCOS, liver and kidney disease, and possibly even neurodegeneration
Diabetes medications and cancer risk associations: a systematic review and meta-analysis of evidence over the past 10 years
